ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
出版年份 2022 全文链接
标题
ApoE4 reduction: An emerging and promising therapeutic strategy for Alzheimer's disease
作者
关键词
-
出版物
NEUROBIOLOGY OF AGING
Volume 115, Issue -, Pages 20-28
出版商
Elsevier BV
发表日期
2022-03-23
DOI
10.1016/j.neurobiolaging.2022.03.011
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The growth of siRNA-based therapeutics: updated clinical studies
- (2021) M. May Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Astrocytic ApoE reprograms neuronal cholesterol metabolism and histone-acetylation-mediated memory
- (2021) Xiaohui Li et al. NEURON
- Apolipoprotein E4 Reduction with Antisense Oligonucleotides Decreases Neurodegeneration in a Tauopathy Model
- (2021) Alexandra Litvinchuk et al. ANNALS OF NEUROLOGY
- APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function
- (2021) Monica Xiong et al. Science Translational Medicine
- HMGB1/RAGE/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis
- (2021) Sally A. Abuelezz et al. LIFE SCIENCES
- TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation
- (2021) Lorenza Magno et al. Molecular Neurodegeneration
- Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia
- (2021) Chao Wang et al. NEURON
- Apolipoprotein E and Alzheimer's Disease: Findings, Hypotheses, and Potential Mechanisms
- (2021) Nicole Koutsodendris et al. Annual Review of Pathology-Mechanisms of Disease
- Exploring reported genes of microglia RNA ‐sequencing data: Uses and considerations
- (2021) Thecla A. Wageningen et al. GLIA
- The informed road map to prevention of Alzheimer Disease: A call to arms
- (2021) Eric McDade et al. Molecular Neurodegeneration
- Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms
- (2021) Yang Shi et al. NEURON
- Talking points for physicians, patients and caregivers considering Aduhelm® infusion and the accelerated pathway for its approval by the FDA
- (2021) Sam Gandy et al. Molecular Neurodegeneration
- Basal lamina changes in neurodegenerative disorders
- (2021) Benjamin Nguyen et al. Molecular Neurodegeneration
- Astrocytic ApoE underlies maturation of hippocampal neurons and cognitive recovery after traumatic brain injury in mice
- (2021) Tzong-Shiue Yu et al. Communications Biology
- Therapeutic IDOL reduction ameliorates amyloidosis and improves cognitive function in APP/PS1 mice
- (2020) Jie Gao et al. MOLECULAR AND CELLULAR BIOLOGY
- Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease
- (2020) Yingyue Zhou et al. NATURE MEDICINE
- The multiplex model of the genetics of Alzheimer’s disease
- (2020) Rebecca Sims et al. NATURE NEUROSCIENCE
- APOE in the normal brain
- (2020) Sarah A. Flowers et al. NEUROBIOLOGY OF DISEASE
- APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline
- (2020) Axel Montagne et al. NATURE
- LRP1 is a master regulator of tau uptake and spread
- (2020) Jennifer N. Rauch et al. NATURE
- Antisense oligonucleotides for neurodegeneration
- (2020) Blair R. Leavitt et al. SCIENCE
- The Important Interface Between Apolipoprotein E and Neuroinflammation in Alzheimer’s Disease
- (2020) Courtney M. Kloske et al. Frontiers in Immunology
- Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
- (2020) Tiantian Guo et al. Molecular Neurodegeneration
- Alzheimer’s Patient Microglia Exhibit Enhanced Aging and Unique Transcriptional Activation
- (2020) Karpagam Srinivasan et al. Cell Reports
- Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
- (2020) Emma M. O’Connell et al. Frontiers in Neuroscience
- APOE interacts with tau PET to influence memory independently of amyloid PET in older adults without dementia
- (2020) Alexandra J. Weigand et al. Alzheimers & Dementia
- Antisense Drugs Make Sense for Neurological Diseases
- (2020) C. Frank Bennett et al. Annual Review of Pharmacology and Toxicology
- ApoE Lipidation as a Therapeutic Target in Alzheimer’s Disease
- (2020) Maria Fe Lanfranco et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Association of common genetic variants with brain microbleeds: A Genome-wide Association Study
- (2020) Maria J Knol et al. NEUROLOGY
- Small Molecule Phenotypic Screen Identifies Novel Regulators of LDLR Expression
- (2020) Navasona Krishnan et al. ACS Chemical Biology
- Vascular ApoE4 Impairs Behavior by Modulating Gliovascular Function
- (2020) Yu Yamazaki et al. NEURON
- Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction
- (2019) Daniel A. Nation et al. NATURE MEDICINE
- Pretreatment With PCSK9 Inhibitor Protects the Brain Against Cardiac Ischemia/Reperfusion Injury Through a Reduction of Neuronal Inflammation and Amyloid Beta Aggregation
- (2019) Nattayaporn Apaijai et al. Journal of the American Heart Association
- A Quarter Century of APOE and Alzheimer’s Disease: Progress to Date and the Path Forward
- (2019) Michaël E. Belloy et al. NEURON
- Single-cell transcriptomic analysis of Alzheimer’s disease
- (2019) Hansruedi Mathys et al. NATURE
- Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
- (2019) Yu Yamazaki et al. Nature Reviews Neurology
- A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system
- (2019) Julia F. Alterman et al. NATURE BIOTECHNOLOGY
- Proprotein convertase subtilisin/kexin type 9 (PCSK9) in Alzheimer’s disease: A genetic and proteomic multi-cohort study
- (2019) Cynthia Picard et al. PLoS One
- Carnosic Acid Reverses the Inhibition of ApoE4 on Cell Surface Level of ApoER2 and Reelin Signaling Pathway
- (2019) Maoxiao Feng et al. JOURNAL OF ALZHEIMERS DISEASE
- Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report
- (2019) Joseph F. Arboleda-Velasquez et al. NATURE MEDICINE
- Distinct Signaling Pathways Regulate TREM2 Phagocytic and NFκB Antagonistic Activities
- (2019) Hailan Yao et al. Frontiers in Cellular Neuroscience
- Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β
- (2019) Joseph Therriault et al. JAMA Neurology
- Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype
- (2018) Shruti Mishra et al. BRAIN
- Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation
- (2018) Fan Liao et al. JOURNAL OF CLINICAL INVESTIGATION
- ApoE facilitates the microglial response to amyloid plaque pathology
- (2018) Jason D. Ulrich et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector
- (2018) Chengzhong Wang et al. NATURE MEDICINE
- APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer’s Disease Phenotypes in Human iPSC-Derived Brain Cell Types
- (2018) Yuan-Ta Lin et al. NEURON
- Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer’s disease
- (2018) Rachel E. Bennett et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
- (2018) Samira Parhizkar et al. NATURE NEUROSCIENCE
- Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
- (2018) Xunde Xian et al. eLife
- The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
- (2017) Susanne Krasemann et al. IMMUNITY
- Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
- (2017) Axel Montagne et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The ApoE receptors Vldlr and Apoer2 in central nervous system function and disease
- (2017) Courtney Lane-Donovan et al. JOURNAL OF LIPID RESEARCH
- The Alzheimer’s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway
- (2017) Charlotte Jendresen et al. Journal of Neuroinflammation
- ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
- (2017) Yang Shi et al. NATURE
- Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis
- (2017) Tien-Phat V. Huynh et al. NEURON
- ApoE4 Accelerates Early Seeding of Amyloid Pathology
- (2017) Chia-Chen Liu et al. NEURON
- The E3 ubiquitin ligase IDOL regulates synaptic ApoER2 levels and is important for plasticity and learning
- (2017) Jie Gao et al. eLife
- An Anti-apoE4 Specific Monoclonal Antibody Counteracts the Pathological Effects of apoE4 In Vivo
- (2016) Ishai Luz et al. Current Alzheimer Research
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- ABCA1 Agonist Reverses the ApoE4-Driven Cognitive and Brain Pathologies
- (2016) Anat Boehm-Cagan et al. JOURNAL OF ALZHEIMERS DISEASE
- Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease
- (2016) Francesca Zimetti et al. JOURNAL OF ALZHEIMERS DISEASE
- Meta-analysis of apolipoprotein E levels in the cerebrospinal fluid of patients with Alzheimer's disease
- (2016) Puneet Talwar et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia
- (2016) Felix L. Yeh et al. NEURON
- Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
- (2016) Jeffrey L. Cummings et al. Alzheimers Research & Therapy
- A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins
- (2015) Joseph L. Goldstein et al. CELL
- Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
- (2015) Yuka Atagi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
- (2015) Charles C. Bailey et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice
- (2015) Jin Hu et al. Molecular Neurodegeneration
- The E3 ubiquitin ligase Idol controls brain LDL receptor expression, ApoE clearance, and Aβ amyloidosis
- (2015) Jinkuk Choi et al. Science Translational Medicine
- CSF Apo-E levels associate with cognitive decline and MRI changes
- (2014) Jon B. Toledo et al. ACTA NEUROPATHOLOGICA
- Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer’s disease patients and controls
- (2014) Eduardo Martínez-Morillo et al. ACTA NEUROPATHOLOGICA
- The LXR–Idol Axis Differentially Regulates Plasma LDL Levels in Primates and Mice
- (2014) Cynthia Hong et al. Cell Metabolism
- Cholesterol in brain disease: sometimes determinant and frequently implicated
- (2014) M. G. Martin et al. EMBO REPORTS
- Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
- (2014) Gustavo A Rodriguez et al. Journal of Neuroinflammation
- Anti-ApoE Antibody Given after Plaque Onset Decreases A Accumulation and Improves Brain Function in a Mouse Model of A Amyloidosis
- (2014) F. Liao et al. JOURNAL OF NEUROSCIENCE
- ATP-binding cassette transporter A1: From metabolism to neurodegeneration
- (2014) Radosveta Koldamova et al. NEUROBIOLOGY OF DISEASE
- Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function
- (2014) Angel C. Y. Mak et al. JAMA Neurology
- Cerebrospinal Fluid Apolipoprotein E Concentration and Severity of Cognitive Impairment in Patients With Newly Diagnosed Alzheimer’s Disease
- (2013) Christian Schmidt et al. American Journal of Alzheimers Disease and Other Dementias
- Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
- (2013) D. M. Holtzman et al. Cold Spring Harbor Perspectives in Medicine
- APOE genotype alters glial activation and loss of synaptic markers in mice
- (2012) Yuangui Zhu et al. GLIA
- Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease
- (2012) Carlos Cruchaga et al. HUMAN MOLECULAR GENETICS
- Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
- (2012) Jungsu Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent A Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice
- (2012) N. Bien-Ly et al. JOURNAL OF NEUROSCIENCE
- Apolipoprotein E controls cerebrovascular integrity via cyclophilin A
- (2012) Robert D. Bell et al. NATURE
- Variant of TREM2 Associated with the Risk of Alzheimer's Disease
- (2012) Thorlakur Jonsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- TREM2 Variants in Alzheimer's Disease
- (2012) Rita Guerreiro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood A clearance in a mouse model of -amyloidosis
- (2012) J. M. Castellano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Novel Loss-of-Function PCSK9 Variant Is Associated with Low Plasma LDL Cholesterol in a French-Canadian Family and with Impaired Processing and Secretion in Cell Culture
- (2011) J. Mayne et al. CLINICAL CHEMISTRY
- The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor
- (2011) L. Zhang et al. GENES & DEVELOPMENT
- Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid- Amyloidosis
- (2011) J. Kim et al. JOURNAL OF NEUROSCIENCE
- Association of ApoE and LRP mRNA levels with dementia and AD neuropathology
- (2011) Afia Akram et al. NEUROBIOLOGY OF AGING
- The E3 Ubiquitin Ligase IDOL Induces the Degradation of the Low Density Lipoprotein Receptor Family Members VLDLR and ApoER2
- (2010) Cynthia Hong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Apolipoprotein E4 Causes Age- and Tau-Dependent Impairment of GABAergic Interneurons, Leading to Learning and Memory Deficits in Mice
- (2010) Y. Andrews-Zwilling et al. JOURNAL OF NEUROSCIENCE
- ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling
- (2010) Y. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- APOE epsilon-4 allele and cytokine production in Alzheimer's disease
- (2009) Paolo Olgiati et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Human APOE Isoform-Dependent Effects on Brain -Amyloid Levels in PDAPP Transgenic Mice
- (2009) K. R. Bales et al. JOURNAL OF NEUROSCIENCE
- Overexpression of Low-Density Lipoprotein Receptor in the Brain Markedly Inhibits Amyloid Deposition and Increases Extracellular Aβ Clearance
- (2009) Jungsu Kim et al. NEURON
- Fibrillar amyloid- burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
- (2009) E. M. Reiman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL Receptor
- (2009) Noam Zelcer et al. SCIENCE
- Structural and Quantitative Comparison of Cerebrospinal Fluid Glycoproteins in Alzheimer’s Disease Patients and Healthy Individuals
- (2008) Carina Sihlbom et al. NEUROCHEMICAL RESEARCH
- Anatomically-distinct genetic associations of APOE ɛ4 allele load with regional cortical atrophy in Alzheimer's disease
- (2008) Nicola Filippini et al. NEUROIMAGE
- Prevalence and risk factors of cerebral microbleeds: The Rotterdam Scan Study
- (2008) M. W. Vernooij et al. NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started